GlassScriptPhysician profile
Daniel P Crane
NPI 1952660458
$2,392.79
in general payments reported to CMS, 2019-2025
16 companies · $964 in 2025
The $964 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $293 · 2022: $166 · 2023: $507 · 2024: $351 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,496.39 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $605.34 | 2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Abbvie INC. | $383.84 | 2023-2025 | |
| Mentor Worldwide LLC | $323.76 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $179.73 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Galderma Laboratories, L.P. | $165.57 | 2021-2025 | |
| Aroa Biosurgery Incorporated | $137.99 | 2023 | |
| Endo Pharmaceuticals INC. | $111.35 | 2019 | |
| Sientra, INC. | $81.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $80.01 | 2021-2024 | Exparel |
| Kowa Pharmaceuticals America, INC. | $72.31 | 2023 | Seglentis |
| Dilon Technologies, INC. | $69.07 | 2023-2024 | Hemoblast Bellows |
| Coopersurgical, INC. | $58.12 | 2022 | |
| Merz North America, INC. | $49.27 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $31.83 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $24.79 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $18.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.